7-Day News Cycle Review: Healthcare & Medical

April 26, 2010 (FinancialWire) — The last seven days’ healthcare and medical industry related news included MedQuist Inc. (NASDAQ: MEDQ), Competitive Technologies, Inc. (AMEX: CTT), Analogic Corporation (NASDAQ: ALOG), Manhattan Pharmaceuticals, Inc. (OTCBB: MHAN) and RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN). (To see these and numerous other healthcare and medical industry articles go to http://www.financialwire.net/?s=hlthcrdp)

Here are a few headlines:

Myriad Genetics Makes Advancements In Prostate Cancer Study

Misonix Expands Eastern European Distribution Deal

Ingen Ups Share Count

MedeFile And The More Network Ink JV Agreement

Vist Financial Sells Stake In First HSA

(For more healthcare and medical industry articles go to http://www.financialwire.net/?s=hlthcrdp)

Streaming Research for all companies mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at http://investrend.stocksmart.com/ss/html/hpcompany.html).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[ssryrsyr] [hlthcrmdclqqx]